Treace Medical Concepts Inc (TMCI) — Strategic Asset Allocation Index

Latest as of June 2023: 19.4%

Treace Medical Concepts Inc (TMCI) has a Strategic Asset Allocation Index of 19.4% as of June 2023. Strategic assets (PP&E of $29.09 Million plus long-term investments of $-) total $29.09 Million, measured against net assets of $149.96 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Treace Medical Concepts Inc (TMCI) net asset quality to measure how much of total assets are equity-financed.

SAAI

19.4%
Strategic Assets / Net Assets

Strategic Assets

$29.09 Million
PP&E + LT Investments

PP&E

$29.09 Million
USD

Net Assets

$149.96 Million
USD

Treace Medical Concepts Inc Strategic Asset Allocation Index (2019–2022)

This chart shows how Treace Medical Concepts Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 19.4%, representing strategic assets of $29.09 Million against net assets of $149.96 Million USD. For live market cap and overall valuation, see TMCI stock market capitalisation.

Annual Strategic Asset Allocation Index for Treace Medical Concepts Inc (2019–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Treace Medical Concepts Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See TMCI net assets for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2022 25.3% $15.34 Million $15.34 Million $- $60.53 Million ▲ +22.3 pp
2021 3.1% $2.85 Million $2.85 Million $- $93.07 Million ▼ -103.8 pp
2020 106.8% $829.00K $829.00K $- $776.00K ▲ +70.6 pp
2019 36.3% $1.15 Million $1.15 Million $- $3.16 Million
pp = percentage points